Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E986-93. doi: 10.1152/ajpendo.00325.2003.

Abstract

Adult growth hormone deficiency (AGHD) is associated with osteoporosis. Previous reports have suggested that alterations in parathyroid gland responsiveness to changes in calcium concentration may play a role in the genesis of osteoporosis in untreated AGHD patients. We investigated the endogenous parathyroid hormone [PTH-(1-84)] response to hypocalcemic and hypercalcemic stimuli induced by sodium EDTA and calcium gluconate infusion, respectively, and to PTH-(1-34) infusion in AGHD patients before and during GH replacement (GHR). We have demonstrated that the maximum PTH-(1-84) stimulation and suppression occurred at significantly higher calcium concentrations and in response to smaller changes in calcium concentrations after GHR. The calcemic response to the effects of PTH-(1-34) infusion significantly increased after GHR. The calcium set point (the calcium concentration at which the rate of PTH secretion is one-half of its maximal value) significantly increased in all groups after 3 mo on GHR, and it increased further at 12 mo. Our results suggest increased parathyroid gland sensitivity to smaller changes in serum calcium and increased end-organ sensitivity to the effects of PTH in AGHD patients after GHR. These findings may help us to understand the mechanisms underlying the genesis of osteoporosis in AGHD patients.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Calcium Gluconate
  • Chelating Agents
  • Edetic Acid
  • Human Growth Hormone / administration & dosage*
  • Human Growth Hormone / deficiency*
  • Humans
  • Hypercalcemia / chemically induced
  • Hypercalcemia / drug therapy
  • Hypercalcemia / metabolism*
  • Hypocalcemia / chemically induced
  • Hypocalcemia / drug therapy
  • Hypocalcemia / metabolism*
  • Insulin-Like Growth Factor I / metabolism
  • Middle Aged
  • Parathyroid Glands / drug effects*
  • Parathyroid Glands / metabolism*
  • Parathyroid Hormone / administration & dosage
  • Peptide Fragments / administration & dosage
  • Receptors, Calcium-Sensing / metabolism

Substances

  • Chelating Agents
  • Parathyroid Hormone
  • Peptide Fragments
  • Receptors, Calcium-Sensing
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Edetic Acid
  • Calcium Gluconate